- Home
- VIVS vs AQB Comparison
VIVS vs AQB Comparison
Compare VIVS & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- AQB
- Stock Information
- Founded
- VIVS 2007
- AQB 1991
- Country
- VIVS United States
- AQB United States
- Employees
- VIVS N/A
- AQB N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- AQB
- Sector
- VIVS Health Care
- AQB
- Exchange
- VIVS Nasdaq
- AQB Nasdaq
- Market Cap
- VIVS 4.2M
- AQB 2.9M
- IPO Year
- VIVS N/A
- AQB N/A
- Fundamental
- Price
- VIVS $1.49
- AQB $0.77
- Analyst Decision
- VIVS
- AQB
- Analyst Count
- VIVS 0
- AQB 0
- Target Price
- VIVS N/A
- AQB N/A
- AVG Volume (30 Days)
- VIVS 63.3K
- AQB 139.7K
- Earning Date
- VIVS 06-27-2025
- AQB 08-05-2025
- Dividend Yield
- VIVS N/A
- AQB N/A
- EPS Growth
- VIVS N/A
- AQB N/A
- EPS
- VIVS N/A
- AQB N/A
- Revenue
- VIVS $144,000.00
- AQB N/A
- Revenue This Year
- VIVS $42.38
- AQB N/A
- Revenue Next Year
- VIVS $15.42
- AQB N/A
- P/E Ratio
- VIVS N/A
- AQB N/A
- Revenue Growth
- VIVS 32.11
- AQB N/A
- 52 Week Low
- VIVS $1.41
- AQB $0.47
- 52 Week High
- VIVS $21.96
- AQB $1.94
- Technical
- Relative Strength Index (RSI)
- VIVS N/A
- AQB 50.06
- Support Level
- VIVS N/A
- AQB $0.72
- Resistance Level
- VIVS N/A
- AQB $0.87
- Average True Range (ATR)
- VIVS 0.00
- AQB 0.07
- MACD
- VIVS 0.00
- AQB -0.01
- Stochastic Oscillator
- VIVS 0.00
- AQB 40.16
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.